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Abstract Aequorea green fluorescent protein (GFP) and 
protein A were fused and expressed in Escherichia coil The 
fluorescent native fusion protein (PA-GFP) migrated at 47 kDa 
in SDS-PAGE. However, the non-fluorescent denatured PA- 
GFP migrated at 57 kDa which corresponds to the theoretical 
molecular mass. Although the reason(s) for this mobility shift 
between fluorescent and non-fluorescent molecules remains 
unclear, the small ring structure within the native molecules 
may affect their mobility. The cell extract, prepared from an 
E. coli strain producing PA-GFP, was used in Western and dot 
blots. The sensitivity and specificity of the PA-GFP detection 
were sufficient for rapid and easy screening. 
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(MAPs) in living cells using MAP-GFP fusion proteins. These 
results mean that GFP can be used as a fluorescent tag and as 
a new probe for intracellular protein localization in vivo. 
However, GFP may also be a useful tool in vitro. Here we 
describe the application of GFP  to Western and dot blotting, 
in which a labeled antibody or antibody-specific l gand (such 
as protein A or G) is required. Some enzymes (e.g., peroxi- 
dase, alkaline phosphatase, or [3-galactosidase), gold particles, 
radioisotopes, or fluorochromes are usually used as labeling 
reagents. However, if protein A or G are tagged metabolically 
with GFP  as fusion products, they may allow more simple 
and rapid detection of blotted proteins. In this study we con- 
structed protein A-GFP fusion protein (PA-GFP) and evalu- 
ated it as a labeled antibody-specific l gand in blotting studies. 
2. Materials and methods 
1. Introduction 
Green fluorescent protein (GFP), isolated from the jellyfish 
Aequorea victoria, produces an intense and stable greenish 
fluorescence non-catalytically [1]. Aequorea GFP absorbs 
blue light maximally at 395 nm and emits green light (peak 
emission at 509 nm). GFP  is a monomeric protein of 238 
amino acids [2] with a molecular mass of 27-30 kDa [3,4]. 
The hexapeptide segment (starting at residue 64) functions 
as a fluorescent chromophore that is formed upon cyclization 
of the residues Ser dehydro-Tyr Gly within the hexapeptide, 
by post-translational modification [5]. Although the denatura- 
tion of GFP  causes a loss of fluorescence under some condi- 
tions, it can often be restored by renaturation [6,7]. GFP is 
expressed as a fluorescent product in both prokaryotic and 
some eukaryotic ells, and its excitation and emission spectra 
are indistinguishable from those of native GFP  [8]. GFP  is 
conformationally very stable, and virtually no photobleaching 
occurs. Therefore, GFP  may be useful for monitoring gene 
expression in living cells [9-12]. Moreover, Wang and Hazel- 
rigg [13] have reported that a fusion protein between GFP  and 
exuperantia protein emitted intense fluorescence in living and 
fixed cells during Drosophila oogenesis. Olson et al. [14] also 
analyzed the function of microtubule associated proteins 
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2.1. Bacterial strains and plasmids 
Escherichia coli HB101 and N4830-1 [15] were used as host strains 
for pRIT2T [16], a protein A gene fusion vector (Pharmacia Biotech, 
Sweden). The lambda right promoter in pRIT2T was induced by 
shifting the growth temperature from 30 to 42°C for 90 min in 
N4830-1, and HB101 was used for constitutive expression of the pro- 
moter. Plasmid TU#65 [8], containing Aequorea GFP cDNA, was 
provided by Dr. M. Chalfie (Columbia University, New York, 
USA). E. coli JM109 (pHTK503), a strain producing human neu- 
ron-specific enolase (NSE) [17], was used for blotting studies. 
2.2. Plasmid construction 
A modified GFP cDNA was prepared from plasmid TU#65 by 
standard PCR using the following primers: 5'-CCCGAATTCCAT- 
GAGTAAAGGAGAAGAACTTTTCAC-3' and 5'-AAAGGATCC- 
CTATTATTTGTATAGTTCATCCA-3' (EcoRI and BamHI sites are 
underlined). The fragment was cloned into pRIT2T by standard pro- 
cedures. Enzymes were purchased from Gibco BRL, USA, or from 
Nippon Gene Co., Japan. DNA was transformed into E. coli HB101 
or N4830-1 with CaC12 [18], and transformants were selected on LB 
agar plates containing 50 ktg ampicillin/ml. Recombinant plasmids 
were isolated as described by Birnboim and Doly [19] with slight 
modifications, then analyzed by agarose gel electrophoresis. DNA 
was sequenced using a fluorescence imaging analyzer FMBIO-100 
(Takara Shuzo Co. Ltd., Japan). 
2.3. Expression and purification of PA-GFP from E. co li 
The HB101 strain harboring pPAGFP127 was grown on LB agar 
plates at 37°C. One day after plating, the incubation temperature was 
shifted to 25°C. Cells were collected from 19 plates after a 3-day 
incubation of 25°C. Cells (approximately 3.4 g, wet weight) were 
then suspended in 9.5 ml of 20 mM Tris-HC1 buffer (pH 8.0) contain- 
ing 10 mM EDTA and 30 mM NaC1 (TEN buffer), and disrupted by 
sonic oscillation. 2 ml of the supernatant, obtained by centrifugation 
at 27 000 xg, was diluted 1:10 with TEN buffer and used as the 'PA- 
GFP working solution' for the blotting studies. The remaining super- 
natant was applied to a column (1.5 x 10 cm) containing rabbit IgG 
immobilized on Sepharose 6B. The column was washed with TEN 
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Fig. 1. Construction of the recombinant plasmid pPAGFP127 and SDS-PAGE of PA-GFP expressed in E. coli. (a) A 0.75 kb Aequorea GFP 
cDNA was modified and amplified by PCR, then digested with EcoRI and BamHI, and cloned into pRIT2T. Transcription of the fusion pro- 
tein (PA-GFP) was controlled by the lambda right promoter in pRIT2T. (b) Strains harboring pRIT2T or pPAGFP127 were grown on LB 
agar plates at 370C (1 day), followed by 25°C (3 days). Cells collected from 2 plates (about 0.3 g) were suspended in 1 ml of TEN buffer and 
sonicated. Supernatant (1 Ixl) obtained after centrifugation was resolved by SDS-PAGE. The cell extract, prepared from strains harboring 
pRIT2T (lanes 2 and 4) or pPAGFP127 (lanes 3 and 5), were stained with CBB (lanes 2 and 3) or irradiated by UV light at 365 nm (lanes 4 
and 5). Molecular mass markers are shown in lane 1. 
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buffer and the bound materials were eluted with the same buffer con- 
taining 9 M urea. Fractions emitting reen fluorescence under a UV 
light at 365 nm (MANASLULIGHT, Manaslu Chemical Industry Co. 
Ltd., Japan) were pooled and dialyzed against TEN buffer. 
2.4. Electrophoresis and immunoblotting 
Proteins were separated on 0.1% SDS-14% polyacrylamide g ls ac- 
cording to Laemmli [20]. SDS-PAGE molecular mass standards kit 
was purchased from Bio-Rad Laboratories, USA. The separated pro- 
teins were stained with 0.25% Coomassie brilliant blue (CBB) R-250, 
or electroblotted onto nitrocellulose membranes. Proteins were dot 
blotted using the Easy-Titer<~ ELIFA system (Pierce Chemical Co., 
USA). 
The blotted proteins were visualized by means of conventional color 
detection or fluorescent detection using PA-GFP. After blocking (1 h 
at 25°C) with 3% BSA and an incubation (1 h at 31°C) with rabbit 
antiserum to human NSE (Eiken Chemical Co. Ltd., Japan), the 
bound antibody was visualized after an incubation for 20 min in 
PA-GFP working solution. The greenish fluorescent bands or spots 
were detected under a UV light at 365 nm, and recorded on Polapan 
3200B (Polaroid Corp., USA) using a green filter. For color detection, 
the bound antibody was visualized with POD-labeled sheep antibody 
against rabbit IgG and DAB (Sigma Chemical Co., USA) as described 
by Hawkes et al. [21]. 
3. Results and discussion 
3.1. Construction and expression of PA-GFP 
The Aequorea GFP cDNA was modified by PCR using the 
plasmid TU#65 [8] as a template. The amplified fragment 
(0.75 kb), containing EcoRI or BarnHI site at each end, was 
digested with these enzymes and cloned into the protein A 
fusion vector pRIT2T. The resulting plasmid, pPAGFP127, 
carried a fused protein A-GFP cDNA encoding a protein of 
about 60 kDa composed of 500 amino acids (except for the 
initiating methionine residue) downstream from the lambda 
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right promoter (Fig. la). The cell extracts prepared from 
E. coli strains harboring pRIT2T or pPAGFP127 were ana- 
lyzed by SDS-PAGE (Fig. lb). PA-GFP was not detected as a 
major band by CBB staining (lane 3). However, a strong 
greenish fluorescent band of 47 kDa, and a weak 43-kDa 
band were visualized by UV-irradiation only in the sample 
from the strain harboring pPAGFP127 (lane 5). The major 
(47 kDa) and minor (43 kDa) fluorescent bands were thought 
to be PA-GFP and its degradation product, respectively; but 
the molecular mass differed considerably from the theoretical 
value (60 kDa). 
The lambda right promoter is commonly induced by shift- 
ing the growth temperature from 30 to 42°C for 90 min in 
E. coli N4830-1, which produces a temperature sensitive re- 
pressor [15]. However, fluorescent PA-GFP was not expressed 
by this standard induction procedure (data not shown). In- 
stead, fluorescent PA-GFP was expressed most efficiently in E. 
coli HB101 constitutively at 25°C (or below) on agar rather 
than in liquid medium. The fluorescence intensity increased 
gradually, reaching a maximum at 3-5 days, at low tempera- 
ture under oxygen rich conditions on plates, rather than by 
the faster expression at higher temperatures. Although the 
mechanism is still unclear, GFP  must be modified post-trans- 
lationally to acquire fluorescent activity. Inouye and Tsuji [22] 
have reported that the fluorescent intensity of intact dequorea 
GFP expressed in E. coli cells increases in harvested cells 
stored overnight at room temperature. Lim et al. [23] have 
also reported the thermosensitive formation of fluorescent 
GFP  in Saccharomyces cerevisiae. These reports and our re- 
suits suggest hat many parameters of cell growth (e.g., tem- 
perature, oxygen, and expression time) are important for the 
formation of fluorescent GFP. 
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Fig. 2. SDS-PAGE of purified PA-GFP. PA-GFP was purified as described in section 2. After dialysis, the fraction containing PA-GFP (5.2 
ml) was resolved by SDS-PAGE. Purified PA-GFP (20 pl) was directly loaded on the gel (lanes 2 and 4) or after heating of 95°C for 5 min 
(lanes 3 and 5). PA-GFP was stained with CBB (lanes 2 and 3) or irradiated by UV light at 365 nm (lanes 4 and 5). Fluorescent and non- 
fluorescent PA-GFP bands are indicated as 'active' and 'inactive', respectively. Molecular mass markers migrated in lane 1. 
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Fig. 3. Comparison of PA-GFP and conventional POD/DAB detection. (a) Purified R-NSE [17] (3.13-400 ng) was blotted onto a nitrocellulose 
membrane as 4 mm spots. (b) The E. coli cell extract prepared from the R-NSE non-producing strain, harboring pKK223-3 (lanes 1, 3 and 5), 
or the R-NSE producing strain, harboring pHTK503 (lanes 2, 4 and 6), were resolved by SDS-PAGE and electroblotted as described [17]. The 
separated proteins were stained with CBB (lanes 1 and 2), and the R-NSE band was detected with POD/DAB system (lanes 3 and 4) or PA- 
GFP (lanes 5 and 6) as described in section 2. 
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3.2. Electrophoretic analysis of  purified PA-GFP 
To clarify molecular properties of fluorescent PA-GFP in 
E. coli cells, purified PA-GFP was prepared from cell extracts 
of the strain harboring pPAGFP127 using a column contain- 
ing rabbit IgG coupled to Sepharose 6B. As shown in Fig. 2, 
purified PA-GFP migrated as major bands at 47 kDa and 57 
kDa; but only the former band was fluorescent. When the 
sample was denatured by heating, only one non-fluorescent 
band was detected at 57 kDa position, corresponding to the 
upper band in lane 2. The theoretical molecular mass of PA- 
GFP is about 60 kDa. Therefore, these results indicate that 
the upper band in lane 2 is non-fluorescent (inactive) PA- 
GFP, and that the lower band is fluorescent (active) PA- 
GFP although it did not correspond to the theoretical mole- 
cular mass. It is still unclear whether inactive PA-GFP is an 
artifact of purification and/or it is an extant cellular compo- 
nent. 
Intact Aequorea GFP expressed in E. coli cell migrated at 
about 40 kDa as a greenish fluorescent band in SDS-PAGE 
[22]. This did not correspond to the theoretical molecular 
mass (28 kDa), but heat-denatured (non-fluorescent) GFP mi- 
grated at the position predicted for its theoretical mass. There- 
fore, when active GFP molecules were inactivated, the mobil- 
ity in SDS-PAGE shifted from the upper (40 kDa) to the 
lower position (28 kDa). In contrast with this report, our 
results indicate that protein A-fused GFP molecules hifted 
from the lower (47 kDa) to the upper position (57 kDa) 
when the active molecules were denatured. This may be 
caused by the fusion, but is difficult to explain. However, at 
least, from these results, we speculate as follows: (i) in SDS- 
PAGE, the formation of an imidazolone ring within GFP 
influences the mobility of the molecule; (ii) PA-GFP is not 
denatured completely by SDS alone owing to the ring struc- 
ture; and (iii) such partially denatured PA-GFP migrates at 
the different position from the PA-GFP denatured completely 
by SDS and heating, because both PA-GFPs differ in part of 
conformation and amount of SDS binding to the molecules. 
3.3. Application of PA-GFP to immunoblotting 
Dot and Western blots were performed using cell extracts 
prepared from the E. coli strain harboring pPAGFP127, and 
the sensitivity and specificity were compared with those of the 
standard POD/DAB system. Dot blots of purified recombi- 
nant human NSE (R-NSE) [17] are shown in Fig. 3a. The 
POD/DAB system was slightly more sensitive than PA-GFP 
detection. However, the sensitivity of PA-GFP detection was 
clearly sufficient for rapid and easy screening. The cell extract 
prepared from the R-NSE producing strain [17] was then ex- 
amined by Western blotting. As shown in Fig. 3b, the speci- 
ficity of PA-GFP detection was identical to that of the POD/ 
DAB system. Though further comparative studies are needed, 
it is clear that PA-GFP can be used in these blotting studies. 
The useful properties of PA-GFP detection are: (i) chemi- 
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cals for detection are not required, therefore the procedure is 
simple, rapid and inexpensive; (ii) the reaction is controlled 
easily by monitoring the fluorescent band under UV light; 
(iii) the fluorescence is stable to UV-irradiation for at least 
30 min; (iv) the fluorescence and binding activity do not de- 
crease when stored (for at least 1 month at 4°C); and (v) 
purification of PA-GFP is not required for blotting: therefore, 
the crude cell extract of the strain harboring pPAGFP127 can 
be applied directly without purification. 
In this study, the second antibody against rabbit IgG was 
not combined in the PA-GFP detection and only a polyclonal 
antibody was examined. If a second antibody is used, the 
sensitivity should increase, which will also allow the detection 
of monoclonal antibodies. 
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